Is "Pangolin (Manis Squama) is not used in medicine" an improvement in the protection of precious and rare species or an improvement in the safety of using medicine?
Journal Title: Traditional Medicine Research - Year 2020, Vol 5, Issue 6
Abstract
Recently, a number of reports about pangolin have become hot news: The Chinese Pharmacopoeia (2020 edition) has not continued to include the drug-using standards for pangolin (Manis Squama), aristolochic (Aristolochia debilis Sieb. et Zucc), celestial vine (Fibraurea recisa Pierre), and Chinese patent drug Huanglian Yanggan pills (approval number by China State Food and Drug Administration: Z200113194). On June 5, 2020, the China Forestry Administration Bureau and the Grassland Bureau co-issued an announcement to upgrade all the species of genus pangolins from the national second level of the protected wildlife to the first level. The new coronavirus (SARS-CoV-2) is also highly similar to the beta coronavirus isolated from pangolin [1]. For a time, “Pangolin is not used in medicine” triggered a hot topic of discussion among the public and the industry. The reason is that China is protecting the precious and rare species from the policy level? Or is it a delayed strategy in the safety of medication? It is worth pondering.
Authors and Affiliations
Bao-Tong Li,Yi Zhou,Xiao-Juan Su,Xiang-Long Meng
Keywords
Related Articles
- EP ID EP690495
- DOI 10.12032/TMR20201001201
- Views 172
- Downloads 0
Study of dual-directional regulatory effect of Banxia (Pinellia ternata) and Huanglian (Coptis chinensis) drug pair on gastrointestinal movement of mice
Objective: To evaluate the regulatory effects of Banxia (Pinellia ternata, P) and Huanglian (Coptis chinensis, C) drug pair, derived from Banxiaxiexin soup, on the gastrointestinal movement of mice with functional dyspep...
Reliability and validity of the Tibetan medicine constitution scale: a cross-sectional study of the general population in Beijing, China
Background: The constitutional theory is an important aspect of Tibetan medicine, however a quantitative measurement tool for constitution identification still does not exist. The objective of this study is to evaluate t...
Complementary and alternative medicine for cancer treatment: magic or fraud?
Quanjian Group, one of biggest health companies in China, is accused of making huge profits by misleading consumers. 18 suspects -- including Shu Yuhui, the largest shareholder of Quanjian Nature Medicine Technology Deve...
Meta-analysis of neostigmine injections given at the Zusanli (ST 36) acupoint in the treatment of postpartum urinary retention
Objective: We aimed to determine the effect of neostigmine injections given at the Zusanli (ST 36) acupoint when treating postpartum urinary retention. Methods: We conducted a systematic review to identify randomized con...
Screening for cyclooxygenase 2 inhibitors from natural compounds of Radix Glycyrrhizae using computer simulation
Objective: To explore the molecular basis of the effects of Gancao (Radix Glycyrrhizae, GC) on inflammation through the inhibition of cyclooxygenase 2 (COX-2). Methods: The Discovery Studio 4.5 System was used to predict...